STARZ-DRP: A TOOL FOR PHARMACY TRIAGE SERVICES
Â Objective: The aims of this study are to demonstrate a feasibility study, using an approach, known as STARZ-DRP to counsel people about health complaints and identify drug-related problem (DRPs).
Methods: This study involved community pharmacists (CPs) in the state of Penang, Malaysia, randomly selected as study and control groups, recruiting patients to involve in this study according to the inclusion and exclusion criteria, excepting for control group which were conducted by trained interviewers. The patients had to involve in two-phase study, baseline and post-study. The study pharmacists had been trained to follow the framework known as STARZ-DRP.
Results: Nine CPs agreed to involve in this study, were randomly selected as study (n=5) and control (n=4), recruiting 617 and 636 patients (study, control) accordingly. More male (study = 52.7%; control = 58.2%) were recruited. Cough (study = 23.0%) and nasal problem (control = 29.9%) were indicated as the highest chief complaint by the patients. 81.8% and 37.1% of study and control patients should be referred to general practitioners. Significant differences were observed when comparing the mean Â± standard deviation of DRPs between the groups and baseline versus post-study.
Conclusion: STARZ-DRP is promoted as a tool to make triaging decision with evidence base at community pharmacy settings.
2. Bolanos BS. Responsible self-medication in latin America. Drug Inf J 2005;39:99-107.
3. Verma RK, Mohan L, Pandey M. Evaluation of self medication among professional student in North India: Proper statutory drug control must be implemented. Asian J Pharm Clin Res 2010;3:60-4.
4. You JH, Wong FY, Chan FW, Wong EL, Yeoh EK. Public perception on the role of community pharmacists in self-medication and self-care in Hong Kong. BMC Clin Pharmacol 2011;11:19.
5. Vohra S. A community pharmacy minor ailment scheme â€“ Effective, rapid, and convenient. Pharm J 2006;276(7406):754-6.
6. Paudyal V, Hansford D, Cunningham S, Stewart D. Pharmacy assisted patient self care of minor ailments: A chronological review of UK health policy documents and key events 1997-2010. Health Policy 2011;101:253-9.
7. Cipolle RJ, Strand LM, Morley PC. Pharmaceutical Care Practice: The Clinicianâ€™s Guide. 2nd ed. New York: McGraw-Hill; 2004.
8. SPSS. Statistical Package for the Social Sciences. (SPSS 18) for Windows. Version 18. Chicago: SPSS Inc.; 2010.
9. Oshikoya KA, Senbanjo IO, Njokanma OF. Self-medication for infants with colic in Lagos, Nigeria. BMC Pediatr 2009;9:9.
10. Awad A, Eltayeb I, Matowe L, Thalib L. Self-medication with antibiotics and antimalarials in the community of Khartoum State, Sudan. J Pharm Pharm Sci 2005;8:326-31.
11. Covington TR. Non prescription medications and self-care. Non prescription drug therapy: Issues and opportunities. Am J Pharm Educ 2006;70:137.
12. Afolabi AO. Drug use and misuse in an adult Nigerian population. Clin Rev J 2007;68:7-14.
13. Smith M, Bates DW, Bodenheimer T, Cleary PD. Why pharmacists belong in the medical home. Health Aff (Millwood) 2010;29:906-13.
14. Blenkinsopp A, Paxton P, Blenkinsopp J. Symptoms in the Pharmacy: A Guide to the Management of Common Illness. 5th ed. Oxford, UK: Blackwell Publishing; 2005. p. 1-13.
15. Edwards C, Stillman P. Minor Illness or Major Disease? The Clinical Pharmacist in the Community. 4th ed. London: Pharmaceutical Press; 2006. p. 1-10.
16. Rutter P. Community Pharmacy: Symptoms, Diagnosis and Treatment. London: Churchill Livingstone, An Imprint of Elsevier Limited; 2004. p. 9-11.
17. Rutter PM, Horsley E, Brown DT. Evaluation of community pharmacistsâ€™ recommendations to standardized patient scenarios. Ann Pharmacother 2004;38:1080-5.
18. McCallian DJ, Cheigh NH. The pharmacistâ€™s role in self-care. J Am Pharm Assoc (Wash) 2002;42 5 Suppl 1:S40-1.
19. Buring SM, Kirby J, Conrad WF. A structured approach for teaching students to counsel self-care patients. Am J Pharm Educ 2007;71:8.
20. Sarriff A, Nordin N, Hassali MA. STARZ-DRP: A step-by-step approach for pharmacy triage services. Mal J Pharm 2011;1(9):311-25.
21. Allen LV. A History of Pharmaceutical Compounding. Vol. 11. No (3). Oklahoma City: Paddock Lab Inc.; 2011. Available from: http://www.perrigo.com/business/pdfs/Sec%20Artem%2011.3.pdf.
22. Yamamura S, Yamamoto N, Oide S, Kitazawa S. Current state of community pharmacy in Japan: Practice, research, and future opportunities or challenges. Ann Pharmacother 2006;40:2008-14.
23. Poudel A, Khanal S, Kadir A, Palaian S. Perception of Nepalese community pharmacists towards patient counseling and continuing pharmacy education program: A multicentric study. J Clin Diagn Res 2009;2(3):1408-13.
24. Salim AM, Elgizoli B. Exploring self-perception of community pharmacists of their professional identity, capabilities, and role expansion. J Res Pharm Pract 2016;5:116-20.
25. Malangu N. The future of community pharmacy practice in South Africa in the light of the proposed new qualification for pharmacists: Implications and challenges. Glob J Health Sci 2014;6:226-33.
26. Warchal S, Brown D, Tomlin N, Portlock J. Attitudes of successful candidates of supplementary prescribing courses to their training and their extended roles. Pharm J 2006;276:348-52.
27. Berbatis CG, Sunderland VB, Joyce A, Bulsara M, Mills C. Enhanced pharmacy services, barriers and facilitators in Australiaâ€™s community pharmacies: Australiaâ€™s National Pharmacy Database Project. Int J Pharm Pract 2007;15(3):185-91.
28. Holland R. When to refer. Pharmaceutical Society of Australia. Sydney: Pharmaceutical Society of Australia; 1993. p. 15.
29. Abay SM, Amelo W. Assessment of self-medication practices among medical, pharmacy, and health science students in Gondar University, Ethiopia. J Young Pharm 2010;2:306-10.
30. Lucas R, Lunet N, Carvalho R, Langa J, Muanantatha M, Nkunda LP, et al. Patterns in the use of medicines by University students in Maputo, Mozambique. Cad Saude Publica 2010;23(12):2845-52.
31. Sostres C, Gargallo CJ, Lanas A. Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage. Arthritis Res Ther 2013;15 Suppl 3:S3.
32. Al-Saeed A. Gastrointestinal and cardiovascular risk of nonsteroidal anti-inflammatory drugs. Oman Med J 2011;26:385-91.
33. Teichert M, Griens F, Buijs E, Wensing M, De Smet PA. Effectiveness of interventions by community pharmacists to reduce risk of gastrointestinal side effects in nonselective nonsteroidal anti-inflammatory drug users. Pharmacoepidemiol Drug Saf 2014;23:382-9.
34. Bear MD, Bartlett D, Evans P. Pharmacist counseling and the use of nonsteroidal anti-inflammatory drugs by older adults. Consult Pharm 2017;32:161-8.
35. Cooper RJ. Over-the-counter medicine abuse â€“ A review of the literature. J Subst Use 2013;18:82-107.
36. HÃ¤mmerlein A, Griese N, Schulz M. Survey of drug-related problems identified by community pharmacies. Ann Pharmacother 2007;41:1825-32.
37. FrÃ¸kjÃ¦r B, Bolvig T, Griese N, Herborg H, Rossing C. Prevalence of drug-related problems in self-medication in Danish community pharmacies. Innov Pharm 2012;3(4):1-10.
38. Wong FY, Chan FW, You JH, Wong EL, Yeoh EK. Patient self-management and pharmacist-led patient self-management in Hong Kong: A focus group study from different healthcare professionalsâ€™ perspectives. BMC Health Serv Res 2011;11:121.
39. LalibertÃ© MC, Perreault S, Damestoy N, Lalonde L. Ideal and actual involvement of community pharmacists in health promotion and prevention: A cross-sectional study in Quebec, Canada. BMC Public Health 2012;12:192.
40. Fang Y, Yang S, Zhou S, Jiang M, Liu J. Community pharmacy practice in China: Past, present and future. Int J Clin Pharm 2013;35:520-8.
41. Austin Z, Gregory PA, Martin JC. Negotiation of interprofessional culture shock: The experiences of pharmacists who become physicians. J Interprof Care 2007;21:83-93.
42. Blake KB, Madhavan SS. Perceived barriers to provision of medication therapy management services (MTMS) and the likelihood of a pharmacist to work in a pharmacy that provides MTMS. Ann Pharmacother 2010;44:424-31.
43. Wheeler A, Crump K, Lee M, Li L, Patel A, Yang R, et al. Collaborative prescribing: A qualitative exploration of a role for pharmacists in mental health. Res Social Adm Pharm 2012;8:179-92.
44. Frankel GE, Austin Z. Responsibility and confidence: Identifying barriers to advanced pharmacy practice. Can Pharm J (Ott) 2013;146:155-61.
45. Egorova SN, Akhmetova T. Pharmaceutical counseling: Between evidence-based medicine and profits. Int J Risk Saf Med 2015;27 Suppl 1:S87-8.
46. Sadek MM, Elnour AA, Al Kalbani NM, Bhagavathula AS, Baraka MA, Aziz AM, et al. Community pharmacy and the extended community pharmacist practice roles: The UAE experiences. Saudi Pharm J 2016;24:563-70.
47. Dol HS, Jadhav SS, Pisal MA, Shaikh SK, Shinde VR. Emerging trends in patient counselling: Current scenario. Int J Pharm Pharm Sci 2015;7(10):65-8.
48. Scheerder G, De Coster I, Van Audenhove C. Pharmacistsâ€™ role in depression care: A survey of attitudes, current practices, and barriers. Psychiatr Serv 2008;59:1155-60.
49. Ali H, Zafar F, Alam S, Mallick N, Hasnain H, Naqvi GR, et al. Integration of community setup in pharmaceutical care: Current challenges, perception, facts and opportunities in Pakistan. Int J Pharm Pharm Sci 2016;8(10):138-43.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.